Annual Report 2010 - About Heraeus
Annual Report 2010 - About Heraeus
Annual Report 2010 - About Heraeus
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Biomaterials and Medical Products Business Group –<br />
<strong>Heraeus</strong> Medical<br />
The biomaterials and medical products business group (<strong>Heraeus</strong> Medical) concentrates on medical products for orthopedic<br />
surgery as well as traumatology and biosurgery. It develops, produces, and globally markets biomaterials used in bone and<br />
joint surgery and to stabilize spinal fractures. Core product PALACOS ® , the gold standard among bone cements, has proved<br />
its worth in clinical use for decades.<br />
BUSINESS DEVElOPMENT<br />
People today want to remain mobile and active, even in<br />
their later years. Because of both this trend and demographic<br />
developments, combined with medical and<br />
technological advances, the number of joint implants<br />
continues to grow worldwide. Driven by innovative<br />
products in attractive niche markets, a comprehensive<br />
training program, and the purposeful expansion of its<br />
international sales network, revenues at <strong>Heraeus</strong> Medical<br />
grew by 11.9% to € 67.0 million. Significant growth<br />
rates were achieved in the core business in Europe and<br />
especially in international sales, with key results in the<br />
United States, Asia, and Australia.<br />
With PALACADEMY ® , <strong>Heraeus</strong> Medical provides orthopedic<br />
surgeons, OP staff, pharmacists, and purchasing<br />
agents with individually designed, high-quality continuing<br />
education regarding endoprosthetics. This education<br />
can be in the form of live events as well as eLearning<br />
courses in many countries and languages.<br />
This knowledge is communicated by an interdisciplinary<br />
training team consisting of more than 50 international<br />
experts.<br />
<strong>Heraeus</strong> Medical has joined the US-based Advanced<br />
Medical Technology Association (AdvaMed), making a voluntary<br />
commitment to policies that promote the highest<br />
ethical standards, fast product approval, appropriate compensation,<br />
and access to international markets.<br />
<strong>2010</strong><br />
2009<br />
2008<br />
PRODUCT REVENUE<br />
in € million<br />
56.2<br />
RESEaRCh aND DEVElOPMENT<br />
As the number of joint replacement procedures rises, so<br />
does the risk of infections that can have lasting effects<br />
on patients and health care systems. <strong>Heraeus</strong> Medical<br />
offers innovative products that help minimize the risk<br />
of infection and thus the risk of revision. For that reason,<br />
the business group invested some € 4.3 million in research<br />
and development, a 13% increase in comparison<br />
with the previous year.<br />
59.9<br />
For example, potential bone defects formed after an infection<br />
or revision can be filled with HERAFILL ® beads<br />
G, a resorbable synthetic bone substitute material containing<br />
an antibiotic. HERAFILL ® beads G promotes the<br />
formation of new bone tissue and offers reliable protection<br />
from bacterial infection, thereby promoting bone<br />
healing.<br />
Programs to develop additional products for better<br />
protection against infection have also been initiated.<br />
67.0<br />
47
Change language